Cardiac allograft tolerance induction with limited immunosuppression.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Surgical Research

• Publication date

  1996-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1006/JSRE.1996.0129PMID 8656608
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of the effect of a 5-mg/kg and 10-mg/kg cyclosporine loading dose with single and multiple donor-specific transfusions on rat cardiac allograft survival.

  1994cited by this paper
• Direct induction of class II molecules by cytomegalovirus in rat heart microvascular endothelial cells is inhibited by ganciclovir (DHPG).

  1994cited by this paper
• PROLONGATION OF CANINE PANCREATIC ISLET ALLOGRAFT SURVIVAL WITH COMBINED RAPAMYCIN AND CYCLOSPORINE THERAPY AT LOW DOSES: RAPAMYCIN EFFICACY IS BLOOD LEVEL RELATED1

  1993cited by this paper
• THE RELATIONSHIP OF BLOOD CONCENTRATIONS OF RAPAMYCIN AND CYCLOSPORINE TO SUPPRESSION OF ALLOGRAFT REJECTION IN A RABBIT HETEROTOPIC HEART TRANSPLANT MODEL1

  1993cited by this paper
• Effect of a short course of rapamycin, cyclosporin A, and donor-specific transfusion on rat cardiac allograft survival.

  1993cited by this paper
• Effects of pre- and postengraftment donor-specific transfusions and cyclosporine on the enhancement of experimental allograft survival.

  1992cited by this paper
• Rapamycin and cyclosporine produce synergistic but nonidentical mechanisms of immunosuppression.

  1991cited by this paper
• Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine.

  1991cited by this paper
• Cyclosporine analogues.

  1991cited by this paper
• Enhancement of allograft survival by donor-specific transfusion one day prior to transplant. Importance of timing and specificity when DST is given with cyclosporine.

  1991cited by this paper
• Preclinical evaluation of a new potent immunosuppressive agent, rapamycin.

  1991cited by this paper
• Association of donor-specific blood transfusion enhancement of rat renal allografts with accelerated development of antiidiotypic antibodies and reduced alloantibody responses.

  1990cited by this paper
• (Nva2)-cyclosporine--less potent than cyclosporine A in rats with lung and heart transplants.

  1987cited by this paper
• A comparison of cyclosporine A and Nva2-cyclosporine (cyclosporine G) in a rat renal allograft model.

  1987cited by this paper
• Sparing of suppressor cells: a critical action of cyclosporine.

  1984cited by this paper
• The beneficial transfusion effect on kidney graft survival attributed to clonal deletion.

  1984cited by this paper
• Association of Fc receptor-blocking antibodies and human renal transplant survival.

  1982cited by this paper
• INDUCTION OF SUPPRESSOR CELLS BY DONOR‐SPECIFIC BLOOD TRANSFUSIONS AND HEART TRANSPLANTATION IN RATS

  1981cited by this paper
• Deliberate Donor‐specific Blood Transfusions Prior to Living Related Renal Transplantation: A New Approach

  1980cited by this paper
• Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.

  1975cited by this paper
• Improved technique of heart transplantation in rats.

  1969cited by this paper

• Transient immunosuppression with 15-deoxyspergualin prolongs reporter gene expression and reduces humoral immune response after adenoviral gene transfer

  1998cites this paper
• Analysis of functional renal allograft tolerance with single-dose rapamycin based induction immunosuppression.

  1997cites this paper